Quest to buy Shiel Medical Lab, Updates Expected Revenue, EPS Forecast

Sep 27, 2017

|

NEW YORK (360Dx) – Quest Diagnostics today announced an agreement to buy the Shiel Medical Laboratory business from Fresenius Medical Care.

On Wednesday, Quest also said that it anticipates a 1.5 percent reduction in revenues for the third quarter, due to recent natural disasters in the US and elsewhere. The company also expects a $.10 reduction in EPS and adjusted EPS for the third quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Quest to buy Shiel Medical Lab, Updates Expected Revenue, EPS Forecast

To read the full story....

Breaking News

CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

Agendia Settles Allegations of Medicare Fraud for $8.25M

Noridian Aligns With Palmetto on Single-Gene, Multi-Gene PGx Test Coverage

Demand for SARS-CoV-2 Diagnostic Tests Drives Sharp Increase in 360Dx Index for First Half of 2020

Sysmex Nabs Japan Approval for Automated Hematology Analyzer to Diagnose Malaria

Centogene Gets Emergency Use Authorization for PCR-Based Coronavirus Test

What's Popular?

Demand for SARS-CoV-2 Diagnostic Tests Drives Sharp Increase in 360Dx Index for First Half of 2020

Accelerate, Invitae Lead Gainers as 360Dx Index Ticks Up in June

NanoDiagnostics Closes $18M Series C Round

InBios International Gets Emergency Use Authorization for Second Coronavirus Antibody Test

FDA Grants EUAs for PCR Coronavirus Tests, Nasal Swab Self-Collection Kit

Sponsorships